from 28 settembre 2026 to 2 ottobre 2026
Department of Agricultural Sciences of the University of Napoli Federico II, Portici, Italy
Europe/Rome timezone

Towards a subunit oral vaccine to Newcastle disease in transgenic duckweeds

02 ott 2026, 08:45
15m
Sala Cinese (Department of Agricultural Sciences of the University of Napoli Federico II, Portici, Italy)

Sala Cinese

Department of Agricultural Sciences of the University of Napoli Federico II, Portici, Italy

Piazza Carlo di Borbone, 1, 80055, Portici (NA), Italia

Speaker

Dr. Ron Vunsh (Weizmann Institute for Sciences)

Description

Newcastle virus disease (ND) in poultry is highly contagious. Weak strains cause loss in egg production, virulent strains kill the birds1. NDV virions posses an envelop and contain a single molecule of linear, negative sense RNA coding for at least six proteins. The important proteins for subunit vaccines are two glycoproteins: the hemagglutinin-neuraminidase (HN), and the fusion protein (F), which are used as antigens for immunization. Immunization is currently by injection, nasal spray, ocular or drinking water that contain the HN antigen.

Duckweeds are small, edible monocot plants that float on the surface of fresh water and need only light, air and some common minerals for rapid growth. Plants of these genera are preferred food as indicated by their name. Transgenic edible plants can deliver vaccines to different animals2.

We introduced HN and the F protein genes into a duckweed species to deliver these antigens for induction of protective immune response in chickens. We get high expression of both antigens in the transgenic plants, which grow normally with no apparent phenotypic change.

Keywords

NDV, duckweed, vaccine, chicken

References

1 Moller, L. et al. (2018) Preventive Veterinary Mfdicine,152,41-48.
2 Shaaltiel, Y. Et al. (2007) Plant Biotechnol. J. 5,579-590

Corresponding author email lpron@weizmann.ac.il
Scientific Session Applications

Primary author

Dr. Ron Vunsh (Weizmann Institute for Sciences)

Co-authors

Dr. Maja Cohen (Averma Therapeutics) Dr. Manpreet Kaur (Weizmann Inst.) Dr. Aviva Samach (Weizmann Inst.) Prof. Avraham Levy (Weizmann Inst.) Prof. Marvin Edelman (Weizmann Inst.)

Presentation Materials

There are no materials yet.
Your browser is out of date!

Update your browser to view this website correctly. Update my browser now

×